Ad-hoc | 4 July 2002 14:51

Asclepion-Meditec AG english

Carl Zeiss Meditec AG entered into commercial register – merger concluded Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Carl Zeiss Meditec AG entered into commercial register – merger concluded The merger of Carl Zeiss Ophthalmic Systems AG with Asclepion-Meditec AG (German securities code number 531 370) into Carl Zeiss Meditec AG was officially sealed today when the change was recorded in the commercial register. This was the final step in the integration process, from which the company emerges as one of the world’s leading vendors of ophthalmic devices. Carl Zeiss Meditec AG will continue to be listed on the Neuer Markt at the Frankfurt Stock Exchange. Due to the merger the share capital of presently 6.2 million shares will be increased to 25.8 million shares, each with a nominal value of euro 1.00. The admission of the newly-issued shares to stock trading is to be expedited as soon as possible. Existing shares in Asclepion-Meditec AG will be automatically exchanged for shares in Carl Zeiss Meditec AG at no cost to the shareholders. Contact: Carl Zeiss Meditec AG Jens Brajer/Investor Relations Göschwitzer Strasse 51 -52 D-07745 Jena Telephone: +49 (0) 36 41 – 2 20 – 1 05 Telephone: +49 (0) 36 41 – 2 20 – 1 02 end of ad-hoc-announcement (c)DGAP 04.07.2002 ——————————————————————————– WKN: 531 370; ISIN: DE0005313704; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München, Stuttgart 041451 Jul 02